132 related articles for article (PubMed ID: 37610148)
1. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of prognostic factors in carcinoma ex pleomorphic adenoma.
Key S; Chia C; Hasan Z; Sundaresan P; Dwivedi RC; Riffat F
Oral Oncol; 2022 Oct; 133():106052. PubMed ID: 35921695
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
5. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
6. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
[TBL] [Abstract][Full Text] [Related]
7. Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland.
Nakajima Y; Kishimoto T; Nagai Y; Yamada M; Iida Y; Okamoto Y; Ishida Y; Nakatani Y; Ichinose M
Pathology; 2009; 41(7):634-9. PubMed ID: 19672785
[TBL] [Abstract][Full Text] [Related]
8. Loss of BAP1 Protein Expression by Immunohistochemistry in the Salivary Duct Carcinoma Component of an Intracapsular Carcinoma ex Pleomorphic Adenoma of the Parotid Gland.
Quiroga EF; Connor PR; Rooper L; Moreno MA; Nix JS
Head Neck Pathol; 2023 Sep; 17(3):851-854. PubMed ID: 37594632
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma ex pleomorphic adenoma of the parotid gland.
Park KS; Kim JH; Lee DH; Lee JK; Lim SC
Am J Otolaryngol; 2022; 43(2):103389. PubMed ID: 35149345
[TBL] [Abstract][Full Text] [Related]
10. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
Matsubayashi S; Yoshihara T
Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
[TBL] [Abstract][Full Text] [Related]
13. Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct Carcinoma.
Liang L; Williams MD; Bell D
Head Neck Pathol; 2019 Dec; 13(4):529-534. PubMed ID: 30390196
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
Kim JW; Kwon GY; Roh JL; Choi SH; Nam SY; Kim SY; Cho KJ
J Korean Med Sci; 2011 Oct; 26(10):1277-85. PubMed ID: 22022178
[TBL] [Abstract][Full Text] [Related]
15. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
17. Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis.
Kusafuka K; Kawasaki T; Onitsuka T; Hamaguchi N; Morita K; Mukaigawa T; Nishiya Y; Kamijo T; Iida Y; Nakajima T; Sugino T
Head Neck Pathol; 2020 Mar; 14(1):230-238. PubMed ID: 30484070
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.
Mariano FV; Giovanetti K; Saccomani LF; Del Negro A; Kowalski LP; Krepischi AC; Altemani A
Braz J Otorhinolaryngol; 2016; 82(6):687-694. PubMed ID: 26971045
[TBL] [Abstract][Full Text] [Related]
19. Cytological features of carcinoma ex pleomorphic adenoma of the salivary glands: A diagnostic challenge.
Okano K; Ishida M; Sandoh K; Fujisawa T; Iwai H; Tsuta K
Diagn Cytopathol; 2020 Feb; 48(2):149-153. PubMed ID: 31675185
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
Soares CD; de Lima Morais TM; Carlos R; Martins MD; de Almeida OP; Mariano FV; Altemani A
Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
